Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gel-forming mucins, such as MUC5AC and MUC5B, are large glycoproteins that polymerize to form the structural framework of the mucus gel [1]. This polymerization occurs through the formation of intermolecular disulfide bridges between cysteine-rich domains located at the N- and C-termini of the mucin monomers [2]. These disulfide bonds are essential for the viscoelastic properties of mucus, which are necessary for effective mucociliary clearance and protection of the underlying epithelium [3]. In diseases like cystic fibrosis, COPD, and asthma, the mucus becomes excessively thick and difficult to clear due to increased mucin density and oxidative stress-induced cross-linking [4]. Mucolytic drugs, such as N-acetylcysteine (NAC), target these disulfide bridges by providing free thiol groups that reduce the covalent bonds, thereby breaking the large polymers into smaller, less viscous fragments [5]. This reduction in viscosity facilitates the clearance of mucus from the airways, though it must be balanced against the potential for airway irritation or disruption of the protective barrier [5]. Sources: [1] Thornton DJ, et al. Annu Rev Physiol. 2008;70:459-86. [2] Ridley C, et al. Biochem J. 2003;373(Pt 2):389-97. [3] Fahy JV, Dickey BF. N Engl J Med. 2010;363(23):2233-47. [4] Hansson GC. Nat Rev Gastroenterol Hepatol. 2020;17(9):539-54. [5] Sadowska AM. Paediatr Respir Rev. 2012;13(1):59-64.
Reduction of intermolecular disulfide bonds via thiol-disulfide exchange, leading to the fragmentation of high-molecular-weight mucin polymers and a subsequent decrease in mucus viscosity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Disulfide bridges in gel-forming mucin polymers.